Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Cavender

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Diabetes, Obesity & Metabolism|July 3, 2026
Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult-to-Control Hypertension: An Overview for Primary Care PhysiciansMatthew A Cavender
The Journal of Family Practice|July 13, 2017
Effect of non-insulin-based glucose-lowering therapies on cardiovascular outcomes in patients with type 2 diabetesSzymon L Wiernek, Matthew A Cavender
Journal of Thrombosis and Thrombolysis|May 14, 2010
Bleeding associated with current therapies for acute coronary syndrome: what are the mechanisms?Matthew A Cavender, Sunil V Rao
Diabetes, Obesity & Metabolism|April 7, 2020
Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applicationsColin P O'Leary, Matthew A Cavender
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitusMatthew A Cavender, A Michael Lincoff
Lancet (London, England)|August 19, 2014
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trialsMatthew A Cavender, Marc S Sabatine
Nature Reviews. Cardiology|August 28, 2012
Stent choice and the hidden consequences of cost savingsMatthew A Cavender, Stephen G Ellis
Heart Failure Clinics|September 2, 2019
Hypertension Treatment in Diabetes: Focus on Heart Failure PreventionHannah F Bensimhon, Matthew A Cavender
Interventional Cardiology Clinics|March 6, 2019
Periprocedural Myocardial Infarction in Contemporary PracticeDavid W Lee, Matthew A Cavender
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 22, 2010
Strategies for the development of new PPAR agonists in diabetesMatthew A Cavender, Stephen J Nicholls, A Michael Lincoff
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Diabetes, Obesity & Metabolism|July 3, 2026
Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult-to-Control Hypertension: An Overview for Primary Care PhysiciansMatthew A Cavender
The Journal of Family Practice|July 13, 2017
Effect of non-insulin-based glucose-lowering therapies on cardiovascular outcomes in patients with type 2 diabetesSzymon L Wiernek, Matthew A Cavender
Journal of Thrombosis and Thrombolysis|May 14, 2010
Bleeding associated with current therapies for acute coronary syndrome: what are the mechanisms?Matthew A Cavender, Sunil V Rao
Diabetes, Obesity & Metabolism|April 7, 2020
Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applicationsColin P O'Leary, Matthew A Cavender
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitusMatthew A Cavender, A Michael Lincoff
Lancet (London, England)|August 19, 2014
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trialsMatthew A Cavender, Marc S Sabatine
Nature Reviews. Cardiology|August 28, 2012
Stent choice and the hidden consequences of cost savingsMatthew A Cavender, Stephen G Ellis
Heart Failure Clinics|September 2, 2019
Hypertension Treatment in Diabetes: Focus on Heart Failure PreventionHannah F Bensimhon, Matthew A Cavender
Interventional Cardiology Clinics|March 6, 2019
Periprocedural Myocardial Infarction in Contemporary PracticeDavid W Lee, Matthew A Cavender
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 22, 2010
Strategies for the development of new PPAR agonists in diabetesMatthew A Cavender, Stephen J Nicholls, A Michael Lincoff
Pageof 9